Policy & Regulation
Kibow Biotech introduces kidney probiotic Renadyl in Canada
20 November 2026 -

Kibow Biotech, a developer of probiotic dietary supplements for kidney health, announced on Thursday the availability of its flagship product, Renadyl, in Canada.

Developed through decades of research into the relationship between gut health and kidney function, Renadyl is a patented, clinically studied probiotic supplement scientifically formulated to help maintain healthy kidney function. Its unique approach focuses on the gut microbiome and its role in managing certain waste compounds that can place additional demands on the kidneys.

According to Kibow, Renadyl features a proprietary blend of three probiotic strains delivering 45 billion colony-forming units (CFUs) per daily serving. Designed to work within the intestinal environment, these beneficial bacteria help support the body's natural processes for managing certain waste compounds while promoting a healthier gut environment.

Login
Username:

Password: